After its recognition as a distinct clinical entity, Brugada Syndrome is increasingly recognized worldwide as an important cause of sudden cardiac death. Brugada syndrome exhibits autosomal dominant inheritance with SCN5A, which encodes the cardiac sodium channel, as the only gene with a proven involvement in 20-30% of patients. Its signature feature is ST segment elevation in right precordial ECG leads and predisposition to malignant ventricular tachyarrhythmias. The pathophysiologic mechanism of ST elevation and ventricular tachyarrhythmia, two phenomena strongly related, is controversial. Here, we review clinical and experimental studies as they provide evidence to support or disprove the two hypotheses on the mechanism of Brugada syndrome which currently receive the widest support: (1) nonuniform abbreviation of right ventricular epicardial action potentials ("repolarization disorder"), (2) conduction delay in the right ventricular outflow tract ("depolarization disorder"). We also propose a schematic representation of the depolarization disorder hypothesis. Moreover, we review recent evidence to suggest that other pathophysiologic derangements may also contribute to the pathophysiology of Brugada syndrome, in particular, right ventricular structural derangements.
Introduction
The Brugada Syndrome is characterized by sudden cardiac death from ventricular tachyarrhythmias, in conjunction with a typical ECG signature of ST segment elevation in the right precordial leads [1] [2] [3] . It is inherited in an autosomal dominant fashion. So far, the only gene with a proven involvement is SCN5A, which encodes the cardiac sodium (Na) channel (I Na ) 4 . While its prevalence is unknown, Brugada syndrome may be a leading cause of death among young men in East and Southeast Asia 5, 6 . It may also be responsible for a sizeable proportion of the devastating effect of sudden death in young adults worldwide [7] [8] [9] .With the electrophysiologic mechanisms of the signature ECG and arrhythmias of Brugada syndrome being unknown, the only effective prevention of sudden death so far are implantable cardioverter-defibrillators (ICDs) 10, 11 . Among others, the prohibitive cost of ICDs imparts direct clinical relevance to the elucidation of the pathophysiologic basis of Brugada syndrome. Furthermore, these insights may prove invaluable in increasing our understanding of arrhythmia mechanisms in general, including common acquired disease. Accordingly, the aim of this study is to review clinical and experimental studies to clarify the electrophysiologic mechanisms of Brugada syndrome.
General clinical properties Demography
Since its recognition as a distinct subgroup of idiopathic ventricular fibrillation (VF) in 1992, Brugada syndrome is increasingly described worldwide, although its distribution and prevalence remain unclear 12, 13 . The clinical presentation is heterogeneous and may include palpitations, dizziness, syncope, and (aborted) sudden death, but many subjects are asymptomatic 14, 15 .
Brugada syndrome is endemic in East and Southeast Asia, where it underlies the Sudden Unexpected Death Syndrome
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. It is particularly prevalent in Japan 16 and
Thailand, being the leading cause of sudden death among young men 6 . In China and Korea, the reported incidence is lower [17] [18] [19] . In Europe, Brugada syndrome is extensively described 20, 21 , except in Scandinavian countries 22 . While its prevalence remains unresolved 14 , it is probably rare, with an estimated 5-50 cases per 10.000 9, 23 . In the USA, Brugada syndrome is also rare 24 . Arrhythmic events in Brugada syndrome occur at all ages, from childhood to the elderly, 1, 7, 18, 25 , with a peak around the fourth decade 26 . It is estimated that Brugada syndrome causes 4-12% of all sudden cardiac deaths, and up to 20% among patients without identifiable structural abnormalities 8 .
A striking property is the higher disease prevalence in males, particularly in regions where Brugada syndrome is endemic, despite equal genetic transmission among both genders 6, 26 . That sex hormones may underlie this gender disparity was suggested by the demonstration that castration was associated with attenuation of ST elevation 27 .
Diagnosis and ST segments
The diagnosis revolves around characteristic ST segment elevations. However, the ST segment in Brugada syndrome is typically highly dynamic, exhibiting profound day-to-day, and even beat-to-beat variations in amplitude and morphology 28, 29 .
Of note, accentuation of ST elevation immediately preceding VF 30-32 links these phenomena. .
Pathophysiologic mechanisms of Brugada Syndrome

Evidence of a Functional Basis
Typically, structural cardiac abnormalities are not detected using routine 
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, but other genes still await identification.
More than 50 SCN5A mutations are linked to Brugada syndrome [96] [97] [98] . Their common effect is reduction in I Na , resulting from changes in the functional properties (gating) of the mutant Na channels, or their failure to be expressed in the sarcolemma (trafficking) [99] [100] [101] . 
Proposed Electrophysiologic Mechanisms
The cause of ST elevation in Brugada syndrome and its strong linkage to VT/ VF remain unresolved 75 . The proposed mechanism which presently appears to receive the widest support, both from experimental [108] [109] [110] [111] [112] and clinical studies This dispersion of repolarization also creates a vulnerable window, which allows phase 2 reentry 112 to cause a premature impulse, which triggers VT/VF based on reentry between transmural layers 8, 112, [125] [126] [127] ( Figure 2E ). This hypothesis requires that the AP shape in endocardium remains unaltered by this I Na reduction; this is accounted for by less I to expression in endocardium in many species, including humans 108, 111, 124, [128] [129] [130] [131] . Similarly, the presence of the ECG changes in right, but not left, precordial leads in Brugada syndrome is explained by larger I to expression in RV than LV epicardium 110 , while the higher disease prevalence in males is paralleled by higher epicardial I to density in males than in females
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. 
The Depolarization Disorder Model
An alternative explanation for the signature ST elevations and negative T waves in Brugada syndrome, which does not need to invoke fundamentally different AP shapes, is based on conduction delay in RVOT ( Figure 3 ). The RVOT AP ( Figure   3B , top) is delayed with respect to the RV AP (Fig 3B, bottom) . During the hatched phase of the cardiac cycle in Figure 3D (the phase between the upstroke of the early AP in RV and the upstroke of the delayed AP in RVOT), the membrane potential in the RV is more positive than in the RVOT, thus acting as a source, and driving intercellular current to the RVOT, which acts as a sink ( Figure 3C however, whether this observation truly reflects a repolarization or depolarization disorder is unresolved.
Effects of Autonomic Modulation
Autonomic modulation strongly affects the amplitude of ST elevation in Brugada indicating that abnormal autonomic innervation may cause ST elevation.
Effects of I to Blockade
The repolarization disorder hypothesis predicts that removal of the transmural [153] [154] [155] [156] may also act to suppress reentrant arrhythmias.
Effects of Heart Rate
The 162 .
Right Ventricular Conduction Slowing
While these findings confirm the strong correlation between conduction slowing and VT/VF in Brugada syndrome, validation of the depolarization disorder hypothesis requires that conduction delay is mapped in the RVOT. Accordingly 117 , epicardial electrograms were recorded from the conus branch of the right coronary artery, which runs over the RVOT surface. Activation delay was found here, but not endocardially. Of note, this delay increased with class IC drug challenge. In another study 163 , BSM localized areas of conduction delay to the anterior thorax overlying the RVOT. Conduction delay here increased with I Na blockers and decreased after isoproterenol. Of interest, changes in ARIs paralleled these changes, arguing against premature repolarization. In a study where signal averaged ECGs were calculated from various BSM leads 161 , late potentials coincided with ST elevation and were mapped to the RVOT. The role of RV conduction delay was also confirmed using tissue Doppler echocardiography, as the amplitude of ST elevation in Brugada syndrome patients correlated with delay in RV contraction 116 . Still, some studies failed to document delayed potentials of the right ventricle 37 .
Evidence for Other Pathophysiologic Mechanisms Structural Disorders
Given its predominant RV involvement, some initially considered Brugada syndrome a RV cardiomyopathy, akin to arrhythmogenic right ventricular cardiomyopathy (ARVC), with subtle structural abnormalities not detectable by standard diagnostic tools 58, 93, 164 . Similarities between Brugada syndrome and ARVC were further substantiated by the discovery of SCN5A mutations in an ARVC family 165 . While the discovery of linkage to SCN5A has since drawn attention to functional derangements in Brugada syndrome 4 , recent evidence now rekindles support for an abnormal structural RVOT component in Brugada syndrome.
Electron beam CT scan studies revealed RV enlargement, along with abundant adipose tissue in some patients 166 , and RV wall motion abnormalities whose localization correlated with the origin of spontaneous PVCs following an arrhythmic event 167 . Of note, spontaneous PVCs may originate in the area where VT/VF is most readily inducible during EPS, usually the RVOT free wall 168 .
The link between structural and functional derangements was further tightened by an electron beam CT scan study, in which wall motion abnormalities were exacerbated/provoked 169 . Using cardiac magnetic resonance imaging, a sensitive tool for detection of RV structural abnormalities 170 , significant RVOT enlargement was found in Brugada syndrome patients versus controls 171 . Also, the explanted heart of a Brugada syndrome patient with a SCN5A mutation and electrical storms revealed substantial structural derangements (fatty replacement and intense fibrosis) in RVOT, while the LV was normal. This study found no spike-and-dome configuration in RV epicardium, but prominent conduction slowing, and VT/VF origin in endocardium, not epicardium. These findings argue against the repolarization disorder hypothesis and in favor of the depolarization disorder hypothesis 94 .
Finally, the efficacy of catheter ablation in preventing VT/VF suggests a structural basis of Brugada syndrome 82 .
While these studies demonstrate a link between structural and functional derangements in Brugada syndrome, thereby strengthening the tie between Brugada syndrome and ARVC 172 , recent studies have raised the intriguing possibility that the functional derangements, i.e., I Na reduction, may cause these structural derangements. A girl with compound heterozygosity for two SCN5A mutations exhibited severe degenerative changes in the specialized conduction system 173 , while transgenic mice made haploinsufficient by splicing one SCN5A allele developed cardiac fibrosis as they aged 174 .
The Role of Slow Conducting Tissues
Another explanation for RVOT conduction slowing may involve the presence of slow conducting tissues in the RVOT. Cardiac development may hold the key for this premise, as it may also explain the intriguing prominence of RVOT involvement in Brugada syndrome. The right ventricle has a different embryological origin than the left ventricle 175 , and the outflow tract derives from the same group of cells that compose the atrioventricular region, thus possessing slow conduction properties 176, 177 . While these node-like cells are essential for peristaltic blood movement in the embryonic heart which has yet to develop cardiac valves 178 , remnants of these cells may constitute the substrate for arrhythmias originating in the RVOT 179 . We
here propose that these cells may be incorporated in the depolarization disorder hypothesis in Brugada syndrome (Figure 4 , right panel).
Figure 4: Model of depolarization disorder hypothesis with incorporation of node-like cells in right ventricular outflow tract (right panel, RVOT). Similar to Figure 3, delayed activation of node-like cells causes potential gradients, resulting in coved-type ST elevation (right panel).
This would not only comfortably account for RVOT conduction slowing, but also for the observation that the most severe ST elevations are present in leads overlying the RVOT (Figure 1 .
In conclusion, clinical and experimental studies provide ample evidence to support the depolarization disorder hypothesis in Brugada syndrome, as well as the repolarization disorder hypothesis (see Table) . Similar to most diseases, it is likely that Brugada syndrome is not fully explained by one single mechanism. While most studies reviewed here may provide evidence to support either hypothesis over the other, no study provides irrefutable proof against either hypothesis. Moreover, recent studies highlight the role of other pathophysiologic derangements, e.g.,
fibrosis. The insight now emerges that we must move away from the notion that
Brugada syndrome is a monofactorial disease, because adhering to this notion may hinder the development of rational and effective therapies. Rather, we should perhaps aim for clarification of the contribution of each mechanism in individual Brugada syndrome patients, so as to render rational and effective therapy, tailored to each of these mechanisms, a realistic aim in the near future.
Clinical and Experimental Evidence to Suggest the Electrophysiologic Mechanism of Brugada Syndrome
Support for Repolarization Disorder Hypothesis:
Sodium channel blockers exacerbate/provoke ST elevations
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Linkage with SCN5A mutations exhibiting reduced sodium current 4 Quinidine normalizes ECG and prevents arrhythmias 106, 107, 147 More prevalent phenotype in males 6, 26, 132 ST elevations are usually facilitated by slow heart rates Late potentials indicate increased risk of arrhythmic events 119, 161 Flecainide induces greater QRS widening in Brugada Syndrome patients than in controls
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Conduction delay in right ventricular outflow tract (body surface mapping)
31, 163
Longer HV interval predicts VT/VF inducibility 162 ST elevation correlates with delay in right ventricle contraction 116 Arrhythmogenic area is confined to small RVOT region (initiating PVCs, VT/VF inducibility, efficacy of catheter ablation)
82, 168
Structural derangements, including fibrosis, in histological studies in Brugada Syndrome patients 
